Method of preparing natural human thymosin a1 using series expression mode
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 广东暨大基因药物工程研究中心有限公司
- Publication Date
- 2006-01-25
Abstract
Description
technical field
[0001] The invention relates to a method for preparing biological polypeptides, in particular to a method for preparing natural human thymosin α1 by means of gene serial expression. Background technique
[0002] Thymosin α1 (Thymosin-α1, Tα1) is a polypeptide composed of 28 amino acid residues, with an isoelectric point of 4.2, no secondary structure and no disulfide bond, and the only modification is N-terminal acetylation. Its amino acid sequence is N-Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu- Val-Val-Glu-Glu-Ala-Glu-Asn-C is an immune enhancer targeting T lymphocytes. It can make T cells mature and differentiate, and can promote mature T cells and NK cells to secrete various lymphokines such as interleukin-2 and γ-interferon. -2 receptor (IL-2) production.
[0003] As an immune enhancer, Tα1 is mainly used for immunodeficiency and immunosuppressive diseases. When a patient is infected with certain viruses su...